Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Terminated 4 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Tongue Neoplasms 4 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Squamous Cell 1 Mucositis 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 27 Taxes 9 Capecitabine 8 Albumin-Bound Paclitaxel 6 pembrolizumab 5 Radiosurgery 5 Oxaliplatin 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Specimen Handling 4 Secretin 4 Fluorouracil 4 Drug Therapy 4 Ascorbic Acid 4 durvalumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Irinotecan 3 Cyclophosphamide 3 Cisplatin 3 Biopsy 3 palbociclib 2 methylnaltrexone 2 folfirinox 2 fludarabine 2 entinostat 2 aldesleukin 2 Trastuzumab 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pancreatic Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

NCT03541486 2025-03-10

XACT-PANC-2

University of Iowa

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡